Therapeutic cancer vaccines: are we there yet?, Immunol Rev, vol.239, pp.27-44, 2011. ,
Oncology meets immunology: the cancerimmunity cycle, Immunity, vol.39, pp.1-10, 2013. ,
Dendritic-cell-based therapeutic cancer vaccines, Immunity, vol.39, pp.38-48, 2013. ,
Endolysosomalescape nanovaccines through adjuvant-induced tumor antigen assembly for enhanced effector CD8(+) T cell activation, Small, vol.14, p.1703539, 2018. ,
Vaccination with human papillomavirus-18 E1 protein plus ?-galactosyl-ceramide induces CD8(+) cytotoxic response and impairs the growth of E1-expressing tumors, Vaccine, vol.37, pp.1219-1247, 2019. ,
Beyond antigens and adjuvants: formulating future vaccines, J Clin Invest, vol.126, pp.799-808, 2016. ,
Is there an optimal formulation and delivery strategy for subunit vaccines?, Pharm Res, vol.33, pp.2078-97, 2016. ,
Overview of vaccine adjuvants: introduction, history, and current status, Methods Mol Biol, vol.1494, pp.1-13, 2017. ,
New generation adjuvants-from empiricism to rational design, Vaccine, pp.14-20, 2015. ,
PLGA particulate delivery systems for subunit vaccines: Linking particle properties to immunogenicity, Hum Vaccin Immunother, vol.12, pp.1056-69, 2016. ,
Harnessing dendritic CElls for poly (D,L-lactide-co-glycolide) microspheres (PLGA MS)-mediated antitumor therapy, Front Immunol, vol.10, p.707, 2019. ,
Co-delivery of the NKT agonist alpha-galactosylceramide and tumor antigens to cross-priming dendritic cells breaks tolerance to self-antigens and promotes antitumor responses, Oncoimmunology, vol.6, p.1339855, 2017. ,
Tumor therapy in mice via antigen targeting to a novel, DCrestricted C-type lectin, J Clin Invest, vol.118, pp.2098-110, 2008. ,
Dendritic cell-based nanovaccines for cancer immunotherapy, Curr Opin Immunol, vol.25, pp.389-95, 2013. ,
Targeted delivery of alpha-galactosylceramide to CD8alpha+ dendritic cells optimizes type I NKT cell-based antitumor responses, J Immunol, vol.193, pp.961-970, 2014. ,
Targeting DNGR-1 (CLEC9A) with antibody/MUC1 peptide conjugates as a vaccine for carcinomas, Eur J Immunol, vol.44, pp.1947-55, 2014. ,
Induction of antigen-specific immunity with a vaccine targeting NY-ESO-1 to the dendritic cell receptor DEC-205, Sci Transl Med, vol.6, pp.232-251, 2014. ,
Immune system targeting by biodegradable nanoparticles for cancer vaccines, J Control Release, vol.168, pp.179-99, 2013. ,
Natural killer T cell ligand alpha-galactosylceramide enhances protective immunity induced by malaria vaccines, Int Immunol, vol.28, pp.617-641, 2002. ,
NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells, J Immunol, vol.171, pp.5140-5147, 2003. ,
Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein, J Exp Med, vol.198, pp.267-79, 2003. ,
NKT cells provide help for dendritic cell-dependent priming of MHC class I-restricted CD8+ T cells in vivo, J Immunol, vol.170, pp.2540-2548, 2003. ,
Co-administration of ?-GalCer analog and TLR4 agonist induces robust CD8(+) T-cell responses to PyCS protein and WT-1 antigen and activates memory-like effector NKT cells, Clin Immunol, vol.168, pp.6-15, 2016. ,
Co-delivery of PLGA encapsulated invariant NKT cell agonist with antigenic protein induce strong T cell-mediated antitumor immune responses, Oncoimmunology, vol.5, p.1068493, 2015. ,
Harnessing human cross-presenting CLEC9A(+)XCR1(+) dendritic cells for immunotherapy, Front Immunol, vol.5, p.239, 2014. ,
A potent adjuvant effect of a CD1d-binding NKT cell ligand in human immune system mice, Expert Rev Vaccines, vol.16, pp.73-80, 2017. ,
An AAV vectormediated gene delivery approach facilitates reconstitution of functional human CD8+ T cells in mice, PLoS One, vol.9, p.88205, 2014. ,
Functional human CD141+ dendritic cells in human immune system mice, J Infect Dis, vol.221, pp.201-214, 2020. ,
CD8+ T-cell mediated anti-malaria protection induced by malaria vaccines; assessment of hepatic CD8+ T cells by SCBC assay, Hum Vaccin Immunother, vol.13, pp.1625-1634, 2017. ,
Singlecell multiplexed cytokine profiling of CD19 CAR-T cells reveals a diverse landscape of polyfunctional antigen-specific response, J Immunother Cancer, vol.5, p.85, 2017. ,
Preinfusion polyfunctional anti-CD19 chimeric antigen receptor T cells are associated with clinical outcomes in NHL, Blood, vol.132, pp.804-818, 2018. ,
Persistence of adoptively transferred T cells with a kinetically engineered IL-2 receptor agonist, Nat Commun, vol.11, p.660, 2020. ,
Multifunctional T-cell analyses to study response and progression in adoptive cell transfer immunotherapy, Cancer Discov, vol.3, pp.418-447, 2013. ,
The art of using t-SNE for single-cell transcriptomics, Nat Commun, vol.10, p.5416, 2019. ,
Alternative cross-priming through CCL17-CCR4-mediated attraction of CTLs toward NKT cell-licensed DCs, Nat Immunol, vol.11, pp.313-333, 2010. ,
Studying dendritic Cell-T cell interactions under in vivo conditions, Methods Mol Biol, vol.1584, pp.569-83, 2017. ,
Exosomal pMHC-I complex targets T cell-based vaccine to directly stimulate CTL responses leading to antitumor immunity in transgenic FVBneuN and HLA-A2/HER2 mice and eradicating trastuzumab-resistant tumor in athymic nude mice, Breast Cancer Res Treat, vol.140, pp.273-84, 2013. ,
In vivo imaging of immune cell trafficking in cancer, Eur J Nucl Med Mol Imaging, vol.38, pp.949-68, 2011. ,
Antitumor activity and trafficking of self, tumor-specific T cells against tumors located in the brain, Cancer Immunol Immunother, vol.57, pp.1279-89, 2008. ,